Bilateral Cochlear Implants for Children: Does a Second Implant Improve Language, Psychosocial and Other Outcomes? Severe-profound congenital hearing loss engenders significant costs to society. In 2005, specialised education cost -- on average $25,000 per child, loss of productivity cost -- $6.7 billion, and social security benefits were paid to approximately 129,000 individuals who were unemployed due to hearing loss. If bilateral cochlear implantation results in improved language, social dev ....Bilateral Cochlear Implants for Children: Does a Second Implant Improve Language, Psychosocial and Other Outcomes? Severe-profound congenital hearing loss engenders significant costs to society. In 2005, specialised education cost -- on average $25,000 per child, loss of productivity cost -- $6.7 billion, and social security benefits were paid to approximately 129,000 individuals who were unemployed due to hearing loss. If bilateral cochlear implantation results in improved language, social development, and academic outcomes, the community benefits arising will be greatly improved quality of life for these individuals and significant savings to society. In partnership with Cochlear Ltd, this study will provide some of the first data worldwide comparing the effects of an additional implant on language, social and educational outcomes.Read moreRead less
Preclinical Development Of A Therapeutic Anticancer Antibody To C-Met
Funder
National Health and Medical Research Council
Funding Amount
$435,530.00
Summary
Many common cancers cannot be effectively treated. A range of these cancers (e.g. gastric and lung cancer) display the molecule c-Met on their cell surface. c-Met promotes tumour growth; therefore, blocking c-Met is a promising strategy for treating these cancers. However, no antibodies or drugs that target c-Met have been licensed. The therapeutics that are being developed to target c-Met all have considerable limitations. Thus, there is an opportunity to develop a 'best-in-class' therapeutic.
Improving Employment Outcomes in Early Psychosis: Social and Economic Benefits of Early Intervention. Over 74% of people with psychotic illnesses like schizophrenia, despite wanting to work, are unemployed, more than any other disability group. This project examines an evidence-based method in which young people with psychosis can be effectively supported to return to the competitive labour market. In Australia, unemployment of people with schizophrenia costs $927 million, over half the total il ....Improving Employment Outcomes in Early Psychosis: Social and Economic Benefits of Early Intervention. Over 74% of people with psychotic illnesses like schizophrenia, despite wanting to work, are unemployed, more than any other disability group. This project examines an evidence-based method in which young people with psychosis can be effectively supported to return to the competitive labour market. In Australia, unemployment of people with schizophrenia costs $927 million, over half the total illness costs of schizophrenia. For people with psychosis, unemployment exacerbates social and economic marginalisation. This project aims to reduce the economic cost of unemployment among the mentally ill as well as using employment to reduce social marginalisation of people with mental illness.Read moreRead less
An Integrated Approach For The Efffective Adoptive Immunotherapy Of Cancer
Funder
National Health and Medical Research Council
Funding Amount
$468,119.00
Summary
Killer T lymphocytes can penetrate tumors and their transfer into cancer patients has demonstrated some encouraging results, but this form of immunotherapy remain ineffective in most cancer patients. We propose to improve the tumor trafficking and anti-tumor activities of killer cells by genetically engineering them with proteins that will enable them to recognise and destroy cancer cells. The outcomes of this project will validate this novel approach for treatment of cancer patients.
Utilization Of Gene-engineered T Cells For Enhancing Cancer Immunotherapy
Funder
National Health and Medical Research Council
Funding Amount
$761,656.00
Summary
Killer T lymphocytes can penetrate tumours and their transfer into cancer patients has demonstrated some encouraging results, but this form of therapy and other approaches including vaccination remain ineffective in most cancer patients. In this project, we propose to improve the tumour trafficking and anti-tumour activities of killer cells by genetically engineering them with proteins that will enable them to recognise and destroy cancer cells, whilst minimizing toxicity to normal tissue.
New Strategies For Enhancing Chimeric Antigen Receptor (CAR) T Cell Therapy For Cancer
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
The role of the immune system in cancer is now recognised as highly important, highlighted by the success of immunotherapy in patients. Yet many patients fail to respond to this form of treatment due to low frequency of lymphocytes present at the tumor site. A new form of immunotherapy involving transfer of gene-modified lymphocytes is a potential way to overcome this problem. This project will explore new strategies to enhance the utility of this approach against blood and solid cancers.
Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers. Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation st ....Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers. Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation strategies based on viable brain will maximise the capacity for persons with stroke to reach their full potential for recovery and ensure rehabilitation is more targeted and cost efficient. Improved capacity to benefit from treatment will have ongoing benefits for activity participation and productive living in Australians who experience stroke.Read moreRead less
Generating Stronger And Smarter T Cells For Cancer Therapy
Funder
National Health and Medical Research Council
Funding Amount
$310,332.00
Summary
White blood cells from cancer patients can be modified in the laboratory to react against tumours. These cells can then be given back to the patient, which can sometimes cause cancer regression. However, often the white blood cells lack strength, or they lack the ability to distinguish between tumour and normal tissues of the body. In this project we seek to make stronger and smarter white blood cells that can deliver a lethal hit against tumours without damaging essential organs of the body.